Literature DB >> 5628088

Effect of lysostaphin on staphylococcal carriage in infants and children.

R L Harris, A W Nunnery, H D Riley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5628088

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  10 in total

1.  Production of Lysostaphin by Nonproprietary Method Utilizing a Promoter from Toxin-Antitoxin System.

Authors:  Anna Mądry; Agnieszka Jendroszek; Grzegorz Dubin; Benedykt Wladyka
Journal:  Mol Biotechnol       Date:  2019-10       Impact factor: 2.695

2.  Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium.

Authors:  Huanli Liu; Yuan Gao; Li-Rong Yu; Richard C Jones; Christopher A Elkins; Mark E Hart
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

3.  Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris.

Authors:  Hongliang Zhao; Kristina Blazanovic; Yoonjoo Choi; Chris Bailey-Kellogg; Karl E Griswold
Journal:  Appl Environ Microbiol       Date:  2014-02-21       Impact factor: 4.792

4.  Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors:  K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal:  Appl Microbiol       Date:  1971-09

5.  Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model.

Authors:  John F Kokai-Kun; Scott M Walsh; Tanya Chanturiya; James J Mond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

6.  Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.

Authors:  M W Climo; R L Patron; B P Goldstein; G L Archer
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

7.  Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis.

Authors:  Irina S Barequet; Guy J Ben Simon; Mary Safrin; Dennis E Ohman; Efrat Kessler
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

8.  Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models.

Authors:  Tobias Hertlein; Volker Sturm; Udo Lorenz; K Sumathy; Peter Jakob; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

Review 9.  Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus.

Authors:  Piotr Szweda; Marta Schielmann; Roman Kotlowski; Grzegorz Gorczyca; Magdalena Zalewska; Slawomir Milewski
Journal:  Appl Microbiol Biotechnol       Date:  2012-10-18       Impact factor: 4.813

10.  Immunomimetic Designer Cells Protect Mice from MRSA Infection.

Authors:  Ying Liu; Peng Bai; Anne-Kathrin Woischnig; Ghislaine Charpin-El Hamri; Haifeng Ye; Marc Folcher; Mingqi Xie; Nina Khanna; Martin Fussenegger
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.